FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to neonatology, and can be used for sepsis prevention in newborns. That is ensured by the pre-assay of lymphocytes of late apoptosis in baby's venous blood by flow cytofluorometry technique. If the determined value exceeds 0.56%, the intensive therapy applied is added with the intravenous introduction human recombinant granulocytic colony-stimulating factor (hr-GCSF) in a daily dose 10 mcg/kg. The period of treatment is 3 days.
EFFECT: invention enables well-timed pathogenetic therapy at the preclinical stage with intensifying the intensive therapy applied that promotes lower neonatal sepsis related lethality.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF RESPIRATORY DISTRESS-SYNDROME THERAPY IN NEWBORN BABIES WHO ARE ON ARTIFICIAL LUNG VENTILATION | 2010 |
|
RU2434653C1 |
| EARLY DIAGNOSTIC TECHNIQUE FOR DEVELOPMENT OF NEONATAL SEPSIS IN NEWBORNS SUFFERING FROM RESPIRATORY DISORDER SYNDROME AND HYPOXIC DAMAGE OF CNS | 2008 |
|
RU2374646C1 |
| METHOD OF EARLY PREDICTION OF SEPTIC COMPLICATIONS IN NEWBORNS WITH RESPIRATORY PATHOLOGY | 2009 |
|
RU2414706C1 |
| METHOD FOR PREDICTING THE RESULT OF RESPIRATORY DISTRESS-SYNDROME IN NEONATALS IN CRITICAL STATE | 2006 |
|
RU2318445C1 |
| METHOD FOR PREDICTING RESPIRATORY DISTRESS SYNDROME OUTCOME IN NEWBORNS HAVING PERINATAL CENTRAL NERVOUS SYSTEM INJURY | 2006 |
|
RU2308724C1 |
| DIAGNOSTIC TECHNIQUE FOR PURULENT-SEPTIC COMPLICATIONS IN NEWBORNS | 2011 |
|
RU2484479C1 |
| METHOD FOR PREDICTING THE RESULT OF BACTERIAL INFECTION IN NEWBORN BABIES | 2003 |
|
RU2246729C1 |
| METHOD FOR INFECTIOUS AND INFLAMMATORY PATHOLOGY OUTCOMES PREDICTION FOR EXTREMELY PREMATURE INFANTS | 2016 |
|
RU2619343C1 |
| METHOD OF TREATING PERINATAL AFFECTION OF CENTRAL NERVOUS SYSTEM IN NEWBORNS IN CRITICAL STATE | 2008 |
|
RU2387369C1 |
| METHOD FOR PRECLINICAL DIAGNOSTICS IN THE NEWBORNS WITH RESPIRATORY DISORDERS AND PERINATAL DISEASES OF CNS | 2000 |
|
RU2185628C2 |
